ZVSA - ZyVersa Therapeutics, Inc.
IEX Last Trade
2.41
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:26:20 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.46%
PREVIOUS CLOSE
CHG
CHG%
$2.41
-1.17
0.94%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
10.68%
1 Month
0 0%
3 Months
-47.22%
6 Months
-71.64%
1 Year
36.95%
2 Year
-98.74%
Key data
Stock price
$2.41
DAY RANGE
$1.24 - $2.41
52 WEEK RANGE
$0.84 - $25.00
52 WEEK CHANGE
$39.06
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Daniel J. O'Connor
Region: US
Website: lsprhealth.com
Employees: 2
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: lsprhealth.com
Employees: 2
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Larkspur Health Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was incorporated in 2021 and is based in Bridgewater, New Jersey.
Recent news